← Eichor
Condition: Vaping Related Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Vaping Related Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Phase N/A · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT06552741BREATHE Free: a Pilot Feasibility Trial
NA · 1 location(s) · Augusta University · NCT06862050The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette Reduction
Phase 2 · 1 location(s) · VapeAway · NCT07322432Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
NA · 1 location(s) · Prisma Health-Upstate · NCT07202039TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
NA · 1 location(s) · University of Zurich · NCT07568483Early Detection of Vaping-related Vascular Diseases
Phase N/A · 1 location(s) · University of Miami · NCT05454267Behavioral Intervention for Youth to Promote Vaping Cessation
NA · 1 location(s) · Massachusetts General Hospital · NCT06765291Young Adult Tobacco/Nicotine and Cannabis Co-use
NA · 1 location(s) · Medical University of South Carolina · NCT06239350The Development and Evaluation of a Culturally Grounded ENDS Intervention for Rural Hawaiian Youth
NA · 1 location(s) · University of Hawaii · NCT06929520Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration
Phase 2 · 1 location(s) · University of California, San Francisco · NCT05999383A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06909500Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
Phase 2 · 2 location(s) · University of Vermont · NCT06614504Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05994209The Impact of E-cigarettes During Pregnancy on Childhood Health Outcomes Study
Phase N/A · 3 location(s) · University College Dublin · NCT06297005Effects of Novel E-cigarette Constituents on Adults TCORS 3.0
NA · 1 location(s) · Yale University · NCT05932745Harm Reduction for Smokers With Mental Illness
NA · 2 location(s) · Dartmouth-Hitchcock Medical Center · NCT06543407Effect of Cannabis on E-Cigarette Use Behavior
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06609109Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
Phase 1 · 1 location(s) · University of California, San Francisco · NCT05962229A Trial of Varenicline for E-cigarette Cessation
Phase 2 · 2 location(s) · Yale University · NCT07040566Real-time eCounselling for Nicotine Addiction
NA · 1 location(s) · Overcome · NCT06544057The Canadian Lung Outcomes in Users of Vaping Devices Study
Phase N/A · 8 location(s) · University of British Columbia · NCT06819969Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT07145866Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
NA · 1 location(s) · Brown University · NCT06948058Social Media Support Groups for Adolescent Vaping Cessation
NA · 1 location(s) · University of California, San Francisco · NCT07540780E-cigarette Cessation in Adults Who Co-use Cannabis
Phase 4 · 3 location(s) · Medical University of South Carolina · NCT06688539
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.